Agreed. With less than 1% market penetration PME is just at the beginning of it's growth arc. Contracts sign are early adopters. When there is general acceptance of their technology their revenues will be several times what they are now and margins much higher. And with the founders owning 60% of the company any suitor will have to pay a substantial premium to succeed in a TO. Six bucks is unlikely to be tempt them.
- Forums
- ASX - By Stock
- Ann: PME appoints new Non-Executive Director-PME.AX
Agreed. With less than 1% market penetration PME is just at the...
Featured News
Add PME (ASX) to my watchlist
(20min delay)
|
|||||
Last
$227.64 |
Change
5.890(2.66%) |
Mkt cap ! $17.90B |
Open | High | Low | Value | Volume |
$225.00 | $229.57 | $223.37 | $80.03M | 351.6K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 4 | $227.60 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$227.72 | 3210 | 3 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 1231 | 14.800 |
1 | 1231 | 14.760 |
1 | 293 | 14.750 |
1 | 510 | 14.730 |
1 | 941 | 14.720 |
Price($) | Vol. | No. |
---|---|---|
14.830 | 466 | 1 |
14.840 | 1685 | 1 |
14.860 | 771 | 1 |
14.870 | 677 | 1 |
14.880 | 941 | 2 |
Last trade - 16.10pm 25/11/2024 (20 minute delay) ? |
Featured News
PME (ASX) Chart |
The Watchlist
ACW
ACTINOGEN MEDICAL LIMITED
Andy Udell, CCO
Andy Udell
CCO
SPONSORED BY The Market Online